Processa (PCSA) Chief Administrative Officer Wendy Guy Receives RSU Award

What Happened

• Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals (PCSA), was granted/awarded 9,450 restricted stock units (RSUs) on July 26, 2026. The award shows an acquisition price of $0.00 (no cash paid) and is reported as a derivative award (transaction code A).

Key Details

• Transaction date: 2026-07-26; Form 4 filed: 2026-07-28 (filed timely).
• Amount: 9,450 RSUs granted; reported acquisition price $0.00 (award/compensation, not a purchase).
• Shares owned after transaction: Not specified in the provided filing details.
• Notable footnotes:
  • F1: Each RSU equals the contingent right to one share. The RSUs vested upon grant but will not be distributed until the earlier of: (i) termination; (ii) six-month anniversary of the grant; (iii) change of control; or (iv) death.
  • F2: (Related disclosure) stock option vesting schedule—one-third after one year, remainder over two years (not the subject of this RSU grant).
  • F3: Share amounts reflect the 1-for-25 reverse stock split effective Dec 17, 2025.
• Transaction type: Award/compensation (derivative), not an open-market buy or sale.

Context

• This was a compensation award (RSUs) that vested immediately but is subject to distribution restrictions—common for executive compensation and not a direct market purchase or sale. Because distribution is deferred, these RSUs do not immediately increase tradable shares held by the insider.